Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
International Journal of Molecular Sciences|May 13, 2026
Common Biomarkers of Endothelial Dysfunction Across Highly Prevalent Diseases with Cardiovascular Risk: Functional Characterization and Prognostic ImplicationsJulia Martinez-Sanchez, Sergi Torramadé-Moix, Ana Belén Moreno-Castaño, et al.Frontiers in Immunology|December 30, 2024
Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsiaAlex Ramos, Lina Youssef, Patricia Molina, et al.RMD Open|December 10, 2021
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER studyJose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, et al.Leukemia & Lymphoma|October 17, 2025
Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experienceCarles Tolosa-Ridao, Joan Cid, Luis-Gerardo Rodríguez-Lobato, et al.Lupus Science & Medicine|January 27, 2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN RegistryPaola Vidal-Montal, Aina Fabregat, Irene Altabás-González, et al.Rheumatology International|August 24, 2024
Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)María Jesús Garcia-Villanueva, Sandra Garrote-Corral, Jose María Pego-Reigosa, et al.Frontiers in Immunology|January 23, 2026
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsisAna Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumorsJohann S de Bono, Anja Williams, Ignacio Melero, et al.Autoimmunity Reviews|February 2, 2017
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective studyElena Bartoloni, Miguel A Gonzalez-Gay, Carlo Scirè, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 8, 2019
Complement Activation and Thrombotic MicroangiopathiesMarta Palomo, Miquel Blasco, Patricia Molina, et al.Pageof 8